| No headlines available for RYHEX. |
| | | Morningstar Overall Rating: |  | | Total Assets: | 1.12M | | Category: | Health | | Total Expense Ratio: | % |
|
| PERFORMANCE & RISK | 30-Nov-09 |
| YTD Return: | 20.95% | | 5y Avg Return: | 3.25% | | Rank in Category (ytd): | 52 | | % Rank in Category (ytd): | 31.52% | | Beta (3y): | 0.74 | | Morningstar Risk Rating: | Low |
|
| The investment seeks capital appreciation. The fund invests substantially at least 80% of its net assets in equity securities of Health Care Companies that are traded in the United States and derivatives. Health Care Companies include pharmaceutical companies, companies involved in the research and development of pharmaceutical products and services, companies involved in the operation of health care facilities, and other companies involved in the design, manufacture, or sale of health care-related products or services. It is nondiversified. | | | Fund Profile |
|
Help
0.12 (0.86%) 
Summary
Add RYHEX to Portfolio 
Download Data
